Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16379
Abstract: We read with interest the pharmacovigilance study by Gupta and colleagues, who used the FDA Adverse Event Reporting System (FAERS) to explore the association between tumour necrosis factor (TNF) alpha inhibitors and suicidal behaviors (SB)… read more here.
Keywords: reduced reporting; hidradenitis suppurativa; necrosis factor; alpha inhibitors ... See more keywords